See leaflet
Vetrano®
palbociclib
Indications
- Palbociclib is indicated for the treatment of human epidermal growth factor receptor type 2 (HER2)-negative and hormone receptor(HR)-positive tumors in adult patients with advanced/metastatic breast cancer.
Presentations
- 75 mg x 21 capsules
- 100 mg x 21 capsules
- 125 mg x 21 capsules
- 75 mg x 21 capsules
- 100 mg x 21 capsules
- 125 mg x 21 capsules